Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial

Adam S. Levy, Mark Krailo, Susan Chi, Doojduen Villaluna, Linda Springer, Chris Williams-Hughes, Maryam Fouladi, Amar Gajjar

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial'. Together they form a unique fingerprint.

Medicine & Life Sciences